Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’
Scientists have performed the largest study yet examining drug sensitivity in childhood acute lymphoblastic leukemia across genomic subtypes and its association with treatment response.
Materials provided by St. Jude Children’s Research Hospital. Note: Content may be edited for style and length.
Source link aaaaa